Interventions for preventing oral mucositis for patients with cancer receiving treatment
Interventions for preventing oral mucositis for patients with cancer receiving treatment
Cochrane Review
7 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Pain score control (0 to 4 hours)
placebo |
-3.54 | - | - | Not assessed |
|
Duration of postoperative analgesia
placebo |
8.26 | - | - | Not assessed |
|
Adverse events
placebo |
nan | - | - | Not assessed |
|
Supplemental analgesic requirements (at 4 hours)
placebo |
0.05 | - | - | Not assessed |
|
Time to feeding after surgery
placebo |
nan | - | - | Not assessed |
|
Supplemental analgesic requirements
intravenous analgesia |
0.27 | - | - | Not assessed |
|
Pain score control
infiltration of the incision |
nan | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD011131 |
| Outcomes: | 7 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
7